Periodontal Disease, Tooth Loss Linked to Esophageal, Gastric Cancer
TUESDAY, July 21, 2020 -- Periodontal disease and tooth loss, indicative of oral microbial dysbiosis, are associated with esophageal and gastric adenocarcinoma, according to a research letter published online July 20 in Gut. Chun-Han Lo, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Non-invasive blood test can detect cancer four years before conventional diagnosis methods
(University of California - San Diego) An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with conventional methods. The test detects stomach, esophageal, colorectal, lung and liver cancer. The test detected cancer in 91% of samples from individuals who were asymptomatic when the samples were collected and were only diagnosed with cancer one to four years later. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2020 Category: Cancer & Oncology Source Type: news

NIH awards $1.5M to Baylor Scott & White researchers for esophageal cancer study
(Baylor Scott& White Research Institute) Aiming to find new ways to prevent esophageal cancer, Baylor Scott& White Research Institute received an R01 grant from the NIH's National Institute of Diabetes and Digestive and Kidney Diseases to study the molecular mechanisms that link GERD to Barrett's esophagus and cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 13, 2020 Category: Cancer & Oncology Source Type: news

Odds of Surgery Lower for Black Patients With Esophageal Cancer
THURSDAY, July 9, 2020 -- Black patients with esophageal cancer have a reduced likelihood of receiving surgery, and patients not undergoing surgery have higher mortality, according to a study published online June 4 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news

New guideline: Don't routinely screen for EAC in patients with chronic GERD
(Canadian Medical Association Journal) A new guideline from the Canadian Task Force on Preventive Health Care, based on a rigorous systematic review of the latest evidence, found no benefit of routine screening for esophageal adenocarcinoma (EAC) and precursor conditions (Barrett esophagus and dysplasia) in patients with chronic gastroesophageal reflux disease (GERD). The guideline, published in CMAJ (Canadian Medical Association Journal), recommends physicians in Canada continue current practice to not screen routinely http://www.cmaj.ca/lookup/doi/10.1503/cmaj.190814. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 6, 2020 Category: Cancer & Oncology Source Type: news

NUS researchers uncover a novel protein which drives cancer progression
(National University of Singapore) Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered a protein that drives the progression of esophageal cancer and liver cancer and it could be a promising target for cancer drug development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2020 Category: Cancer & Oncology Source Type: news

Racial disparities in surgery rates for esophageal cancer
(Thomas Jefferson University) Black patients with esophageal cancer are less likely to receive life-saving surgery for early-stage disease than white patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2020 Category: International Medicine & Public Health Source Type: news

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy
(Impact Journals LLC) Volume 11, Issue 25 of Oncotarget reported that Administration of landiolol hydrochloride was found to be associated with reduced incidence of atrial fibrillation after esophagectomy for esophageal cancer in our previous randomized controlled trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2020 Category: Cancer & Oncology Source Type: news

FDA approves nivolumab for esophageal squamous cell carcinoma
Hematology / Oncology News (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Opdivo (nivolumab) for the Treatment of Patients with Advanced Esophageal Squamous Cell Carcinoma (ESCC) After Prior Fluoropyrimidine- and Platinum-based Chemotherapy
PRINCETON, N.J.--(BUSINESS WIRE) June 10, 2020 Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with unresectable advanced, recurrent... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 10, 2020 Category: Drugs & Pharmacology Source Type: news

Trastuzumab combined with trimodality treatment does not improve outcomes for patients
(NRG Oncology) Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 29, 2020 Category: Cancer & Oncology Source Type: news

Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer - Childs DS, Yoon HH, Eiring RA, Jin Z, Jochum JA, Pitot HC, Jatoi A.
PURPOSE: Falls can occur in older cancer patients, but few studies have examined falls in an age-unspecified group of patients with locally advanced esophageal cancer. Because these patients are often administered neuropathy-inducing agents, are weak, and ... (Source: SafetyLit)
Source: SafetyLit - May 27, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Esophageal, Gastric Adenocarcinomas After H. pylori Infection Esophageal, Gastric Adenocarcinomas After H. pylori Infection
Does treatment and eradication of H pylori reduce the risk of future esophageal and proximal gastric cancer?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 27, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Daily Aspirin Tied to Lower Risk of Various Digestive Cancers
Regular aspirin use was associated with a reduced risk for colon, rectal, stomach, esophageal, liver, gallbladder and pancreatic cancers. (Source: NYT Health)
Source: NYT Health - April 21, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Colon and Colorectal Cancer Pancreatic Cancer Liver Cancer Aspirin Esophageal Cancer Gallbladder Stomach Cancer Source Type: news

Taking aspirin once a week can cut the risk of getting several types of cancer, scientists claim
The scientific review, by Milan University in Italy, looked at a range of studies and found regular use of aspirin appeared to reduce the risk of getting stomach and oesophagus cancers by around a third. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2020 Category: Consumer Health News Source Type: news